TELA Bio, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

TELA Bio, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $80.28 million for the year ending 2025.

  • TELA Bio, Inc. showed an increase of +15.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from TELA Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), TELA Bio, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 1,791.0%.
  • Historical annual values: Fiscal year 2025: $80.28 million | Fiscal year 2024: $69.30 million | Fiscal year 2023: $58.45 million | Fiscal year 2022: $41.42 million | Fiscal year 2021: $29.46 million | Fiscal year 2020: $18.21 million | Fiscal year 2019: $15.45 million | Fiscal year 2018: $8.27 million | Fiscal year 2017: $4.25 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: